Should somatostatin or gabexate be given for prophylaxis of pancreatitis in patients undergoing ERCP?


design and interventiOn A search of PubMed was performed to identify all clinical trials published between January 2000 and May 2006 on the use of somatostatin or gabexate mesylate to prevent PEP. Search terms included “somatostatin” or “gabexate” and “endoscopic retrograde cholangiopancreatography”. The reference lists of retrieved articles were searched… (More)
DOI: 10.1038/ncpgasthep0996


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics